Company intelligence
NG BIOTECH
Rapid, mobile, connected diagnostics
About NG BIOTECH
At NG Biotech, we develop, manufacture and commercialise rapid, mobile and connected diagnostics to modernize diagnosis practice worldwide. NG Biotech is a French company specialized in Research & Development, Manufacturing and Marketing of a new generation of "multiplex", "quantitative" and "connected" rapid diagnostics for biomarker analysis and/or therapy monitoring at the Point of Care. NG Biotech’s patented platform is rapid, mobile and connected. It allows to simultaneously analyse up to 9 biomarkers from a biological direct sample such as a single finger-prick drop of blood. The results can be sent via smartphone within five minutes. NG Biotech commercializes a range of rapid diagnostic devices covering antimicrobial resistance, women’s health and infectious disease. NG Biotech also proposes custom development partnerships with further manufacturing to support breakthrough innovative ideas with rapid diagnostic needs. Backed by a strong R&D team and 30 years of know-how, NG-Biotech is always at the hedge of technology and can conduct projects from feasibility stage up to CE marking and FDA clearance.
Verified activity
Signals from NG BIOTECH
3 published signals
Presence & Recognition
NG BIOTECH is attending the Veterinary Emergency & Critical Care Society (VECCS) 2026 symposium in Savannah, Georgia, from September 14 to 17, 2026.
Reported by NG BIOTECH
Products & Services
NG BIOTECH launched a new website featuring a clearer and more accessible overview of its diagnostic solutions across four product ranges.
Reported by NG BIOTECH
Partnerships
NG Biotech welcomed Michael Sullivan from Atomo Diagnostics to review ongoing projects and discuss collaboration.
Reported by NG BIOTECH